E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/21/2017 in the Prospect News Convertibles Daily.

Morning Commentary: Jazz Pharmaceuticals, Vipshop trading firm to better despite stock markets’ sag

By Rebecca Melvin

New York, March 21 – A couple of U.S. convertibles were trading better early Tuesday even as stock market indices traded off.

Jazz Pharmaceuticals plc’s 1.875% convertibles due 2021 traded at 107.25, which was up slightly from a late-Monday trade at 107.16. The bonds rose to 107 from 103 on Monday after the Dublin-based pharmaceutical company announced positive drug efficacy results from late-stage drug obstructive sleep apnea studies.

Jazz shares were off $2.45, or 1.7%, to $141.63 early Tuesday.

Vipshop Holdings Ltd.’s 1.5% convertibles due 2019 were also better again, trading early Tuesday at 102.5, which was up from 102.375 late Monday, despite lower shares early Tuesday. Shares were down 50 cents, or 3.5%, at $13.77.

The bonds on Friday has been at 101.75 to 102, according to Trace data.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.